Intelligence · Clinical Pipeline
Pfizer Pipeline
All ClinicalTrials.gov programs at Pfizer — phase, modality, and trial IDs.
- Programs
- 12
Quick answer
Pfizer has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AG-013736
Pfizer
Thyroid Neoplasms
1 trial -
CE-326,597 100 mg QD
Pfizer
Weight Management
1 trial -
Maraviroc
Pfizer
Arthritis, Rheumatoid
1 trial -
PD 0332991
Pfizer
Breast Cancer
1 trial -
PF-03446962
Pfizer
Carcinoma, Hepatocellular
1 trial -
PF-04236921 SC injection
Pfizer
Crohn's Disease
1 trial -
PF-06650833
Pfizer
Rheumatoid Arthritis
1 trial -
PF-06835375
Pfizer
Primary Immune Thrombocytopenia
1 trial -
PH-797804
Pfizer
Pulmonary Disease, Chronic Obstructive
1 trial -
Sasanlimab Prefilled syringe
Pfizer
Carcinoma, Non-Small-Cell Lung
1 trial -
UK-453,061 Dose 1
Pfizer
HIV-1
1 trial -
disitamab vedotin
Pfizer
Urothelial Carcinoma
1 trial
Frequently asked questions
How many pipeline programs does Pfizer have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs